These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Management of severe strongyloidiasis attended at reference centers in Spain. Martinez-Perez A; Roure Díez S; Belhassen-Garcia M; Torrús-Tendero D; Perez-Arellano JL; Cabezas T; Soler C; Díaz-Menéndez M; Navarro M; Treviño B; Salvador F; PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006272. PubMed ID: 29474356 [TBL] [Abstract][Full Text] [Related]
7. Streptococcus pyogenes bacteremia and toxic shock syndrome related to Strongyloides stercoralis hyperinfection: a case report. Cohen R; Finn T; Babushkin F; Shapiro M; Uda M; Grossman T J Med Case Rep; 2018 Nov; 12(1):346. PubMed ID: 30463627 [TBL] [Abstract][Full Text] [Related]
8. Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view. Santiago M; Leitão B Eur J Intern Med; 2009 Dec; 20(8):744-8. PubMed ID: 19892301 [TBL] [Abstract][Full Text] [Related]
9. [Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients]. Corti M; Villafañe MF; Trione N; Risso D; Abuín JC; Palmieri O Rev Chilena Infectol; 2011 Jun; 28(3):217-22. PubMed ID: 21879146 [TBL] [Abstract][Full Text] [Related]
10. Strongyloides hyperinfection in rheumatoid arthritis. Das P; Raghu P; Amit Kumar Dinda ; Garg P Int J Surg Pathol; 2007 Oct; 15(4):391-2. PubMed ID: 17913948 [No Abstract] [Full Text] [Related]
12. Strongyloides stercoralis hyperinfection in systemic lupus erythematosus and the antiphospholipid syndrome. Mora CS; Segami MI; Hidalgo JA Semin Arthritis Rheum; 2006 Dec; 36(3):135-43. PubMed ID: 16949135 [TBL] [Abstract][Full Text] [Related]
13. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. Pornsuriyasak P; Niticharoenpong K; Sakapibunnan A Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):531-4. PubMed ID: 15689061 [TBL] [Abstract][Full Text] [Related]
14. Strongyloides stercoralis hyperinfection in an immunocompetent patient with extreme eosinophilia. Marathe A; Date V J Parasitol; 2008 Jun; 94(3):759-60. PubMed ID: 18605792 [TBL] [Abstract][Full Text] [Related]
15. Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin. Moura EB; Maia Mde O; Ghazi M; Amorim FF; Pinhati HM Braz J Infect Dis; 2012; 16(5):479-81. PubMed ID: 22975175 [TBL] [Abstract][Full Text] [Related]
16. [Strongyloidiasis: who is at risk of severe infection and how to prevent it?]. Merz L Rev Med Suisse; 2015 Apr; 11(470):867-71. PubMed ID: 26050304 [TBL] [Abstract][Full Text] [Related]
18. Hyperinfection syndrome in strongyloidiasis: report of two cases. Lemos LB; Qu Z; Laucirica R; Fred HL Ann Diagn Pathol; 2003 Apr; 7(2):87-94. PubMed ID: 12715333 [TBL] [Abstract][Full Text] [Related]
19. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Turner SA; Maclean JD; Fleckenstein L; Greenaway C Am J Trop Med Hyg; 2005 Nov; 73(5):911-4. PubMed ID: 16282302 [TBL] [Abstract][Full Text] [Related]
20. Strongyloides stercoralis hyperinfection syndrome in patients on prolonged steroid treatment: two case reports. Koticha A; Kuyare S; Nair J; Athvale A; Mehta P J Indian Med Assoc; 2013 Apr; 111(4):272-4. PubMed ID: 24475564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]